| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 15, 2005
Accepted on November 2, 2005
I.R.I.B.H.M., Faculty of Medicine, Free University of Brussels, 808 Route de Lennik, B-1070, Brussels, Belgium; Department of Obstetrics and Gynaecology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Department of Genetics, Erasme Hospital, Free University of Brussels, 808 Route de Lennik, B-1070, Brussels, Belgium
* To whom correspondence should be addressed. E-mail: scostag{at}ulb.ac.be.
Context: Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of ovarian stimulation treatments. Moreover, four mutations of the FSH receptor (FSHr) were recently described in patients presenting with spontaneous OHSS (sOHSS) of the first trimester of pregnancy with normal levels of hCG.
Objective: To look for novel FSHr mutations in patients with sOHSS associated with different levels of hCG and TSH to:1) find new residues important for FSHr activation and specificity, 2) better delineate the pathophysiology of the different presentations of sOHSS.
Design, intervention, patients: After blood sampling, we sequenced the FSHr from genomic Leukocytes DNA, from eight patients with the sOHSS of the first or second trimester of pregnancy with normal or high hCG levels, or with high TSH levels associated with severe hypothyroidism.
Setting: University laboratory
Main outcome measure: FSHr sequencing and in vitro evaluation of the variation of cAMP production of FSHr mutants.
Results: A new mutation was found in the patient with sOHSS of the first trimester of pregnancy with normal hCG level: I5.54545T, in transmembrane helix V of the FSHr. When tested functionally, this mutant displayed promiscuous activation by both hCG and TSH, together with detectable constitutive activity. In contrast, no mutations were found in the FSHr from the patients with high hCG or TSH levels indicating that, for those seven patients, sOHSS results from the natural promiscuous stimulation of a wild-type FSHr by very high concentrations of hCG or TSH.
Conclusions: sOHSS can at least occur by three different pathophysiological mechanisms.
This article has been cited by other articles:
![]() |
F. Grochal, C. D. Turner, A. L. Chern, J. Wilters, and P. Jeanty Sonographic Detection of the Ovarian Hyperreactio Luteinalis in Pregnancy Journal of Diagnostic Medical Sonography, November 1, 2008; 24(6): 369 - 373. [Abstract] [PDF] |
||||
![]() |
J. Royer, A. Lefevre-Minisini, G. Caltabiano, T. Lacombe, Y. Malthiery, F. Savagner, L. Pardo, and P. Rodien The Cloned Equine Thyrotropin Receptor Is Hypersensitive to Human Chorionic Gonadotropin; Identification of Three Residues in the Extracellular Domain Involved in Ligand Specificity Endocrinology, October 1, 2008; 149(10): 5088 - 5096. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Bogorad, C. Courtillot, C. Mestayer, S. Bernichtein, L. Harutyunyan, J.-B. Jomain, A. Bachelot, F. Kuttenn, P. A. Kelly, V. Goffin, et al. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors PNAS, September 23, 2008; 105(38): 14533 - 14538. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Feng, T. Muller, D. Mizrachi, F. Fanelli, and D. L. Segaloff An Intracellular Loop (IL2) Residue Confers Different Basal Constitutive Activities to the Human Lutropin Receptor and Human Thyrotropin Receptor through Structural Communication between IL2 and Helix 6, via Helix 3 Endocrinology, April 1, 2008; 149(4): 1705 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Edwards-Silva, C. S. Han, Y. Hoang, and L.-C. Kao Spontaneous Ovarian Hyperstimulation in a Naturally Conceived Pregnancy With Uncontrolled Hypothyroidism Obstet. Gynecol., February 1, 2008; 111(2): 498 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Binder, R. Dittrich, I. Hager, A. Muller, S. Oeser, M. W Beckmann, M. Hamori, P. A Fasching, and R. Strick Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome Reproduction, January 1, 2008; 135(1): 107 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, Y.-X. Tao, G. L. Ryan, X. Feng, F. Fanelli, and D. L. Segaloff Intrinsic Differences in the Response of the Human Lutropin Receptor Versus the Human Follitropin Receptor to Activating Mutations J. Biol. Chem., August 31, 2007; 282(35): 25527 - 25539. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Ryan, X. Feng, C. B. d'Alva, M. Zhang, B. J. Van Voorhis, E. M. Pinto, A. E. F. Kubias, S. R. Antonini, A. C. Latronico, and D. L. Segaloff Evaluating the Roles of Follicle-Stimulating Hormone Receptor Polymorphisms in Gonadal Hyperstimulation Associated with Severe Juvenile Primary Hypothyroidism J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2312 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bonomi, M. Busnelli, L. Persani, G. Vassart, and S. Costagliola Structural Differences in the Hinge Region of the Glycoprotein Hormone Receptors: Evidence from the Sulfated Tyrosine Residues Mol. Endocrinol., December 1, 2006; 20(12): 3351 - 3363. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Allan, A. Garcia, J. Spaliviero, M. Jimenez, and D. J. Handelsman Maintenance of Spermatogenesis by the Activated Human (Asp567Gly) FSH Receptor During Testicular Regression Due to Hormonal Withdrawal Biol Reprod, May 1, 2006; 74(5): 938 - 944. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |